997在线观看视频国产,亚洲av无码专区国产乱码电影

當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

CVT-313
CVT-313(NG-26) is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 (IC50 = 0.5 uM for Cdk2/A and C
2016-01-05 13:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

818.00/5mg
05mg起訂

CCT 137690
CCT 137690 is a potent inhibitor of Aurora kinases (IC50 values are 0.015, 0.019 and 0.025 M at Aurora A, Aurora C and A
2016-01-05 13:21 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

790.00/5mg
05mg起訂

AT7519 (Hydrochloride)
AT7519 hydrochloride is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM; is less potent to CDK3 and
2016-01-04 17:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1488.00/10mg
010mg起訂

Ganetespib
Ganetespib(STA-9090) is a unique triazolone-containing Hsp90 inhibitor with an IC50 of 4 nM in OSA 8 cells.公司介紹：專
2016-01-04 17:27 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

2727.00/10mg
010mg起訂

MK-5108
MK-5108 (VX-689) is a highly selective Aurora A inhibitor with IC50 of 0.064 nM; 220- and 190-fold more selective for Au
2016-01-04 17:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1989.00/5mg
05mg起訂

PF-03814735
PF-03814735 is a novel, potent, orally bioavailable, reversible small-molecule Aurora kinase inhibitor with IC50 of 0.8,
2016-01-04 17:18 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂

Mitoxantrone
Mitoxantrone, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.Target: Topoisomeras
2016-01-04 17:16 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

515.00/50mg
050mg起訂

Poloxin
Poloxin is a non-ATP competitive Polo-like Kinase 1 (PLK1) inhibitor that targets the polo-box domain.公司介紹：專注于各
2016-01-04 17:15 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

577.00/10mg
010mg起訂

BS-181 (hydrochloride)
BS-181 is a highly selective CDK7 inhibitor with IC50 of 21 nM.公司介紹：專注于各種抑制劑、激動劑、及化合物庫，總部位于
2016-01-04 17:13 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

360.00/100mg
0100mg起訂

Cisplatin
Cisplatin(CDDP) is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts.公司
2016-01-04 17:10 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

360.00/100mg
0100mg起訂

TAK-960 (hydrochloride)
TAK-960 hydrochloride is a novel, investigational, orally bioavailable, potent, and selective PLK1 inhibitor(IC50=1.5 nM
2016-01-04 17:08 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1300.00/5mg
05mg起訂

SNS-314
SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respe
2016-01-04 17:06 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

884.00/5mg
05mg起訂

CYC-116
CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM.IC50 Value: 8.0 nM(Aurora A); 9.2 nM(Aurora B)Target
2016-01-04 17:04 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

921.00/10mg
010mg起訂

AT9283
AT9283 is a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and approximate 3 nM for Bcr-Abl(T3151), JAK2 and JAK3, A
2016-01-04 17:02 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂

Alisertib
Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM; has 200-fold higher selectivity for Aurora A
2016-01-04 17:01 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

884.00/5mg
05mg起訂

MK-1775
MK-1775 is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM; hinders G2 DNA damage checkpoint.IC50 Value: 5.2 n
2016-01-04 16:59 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1252.00/5mg
05mg起訂

Y-33075
Y-33075 is potent and selective p160ROCK inhibitor with an Ki value of 0.14 uM,200 fold selectivity for p160ROCK than PK
2016-01-04 16:57 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

2558.00/10mg
010mg起訂

GSK429286A
GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.IC50 Value: 14 nM(ROCK
2016-01-04 16:55 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

1474.00/5mg
05mg起訂

BI 2536
BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and
2016-01-04 16:50 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]

884.00/5mg
05mg起訂

GW843682X
GW843682X is a selective PLK1 and PLK3 inhibitor with IC50s of 2.2 nM(PLK1) and 9.1 nM(PLK3); displays100-fold selectivi
2016-01-04 16:48 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實(shí)]